Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Yanik

Showing results (61-70 of 128) with videos related to

Pageof 13
Sort By:
Cancer Research|December 4, 2001
Vaccination of pediatric solid tumor patients with tumor lysate-pulsed dendritic cells can expand specific T cells and mediate tumor regressionJ D Geiger, R J Hutchinson, L F Hohenkirk, et al.
Bone Marrow Transplantation|January 11, 2005
Stem cell transplantation in patients with severe congenital neutropenia with evidence of leukemic transformationS W Choi, L A Boxer, M A Pulsipher, et al.
European Journal of Cancer (Oxford, England : 1990)|August 31, 2016
Incidence and risk factors for secondary malignancy in patients with neuroblastoma after treatment with (131)I-metaiodobenzylguanidineKelly E Huibregtse, Kieuhoa T Vo, Steven G DuBois, et al.
Pediatric Blood & Cancer|January 3, 2026
Parent-to-Child Information Disclosure in Pediatric OncologyRachel A Kentor, Flora Hoodin, Michelle Byrd, et al.
American Journal of Respiratory and Critical Care Medicine|September 30, 2015
Inhibition of Neutrophil Extracellular Trap Formation after Stem Cell Transplant by Prostaglandin E2Racquel Domingo-Gonzalez, Giovanny J Martínez-Colón, Alana J Smith, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2002
Pilot study of iodine-131-metaiodobenzylguanidine in combination with myeloablative chemotherapy and autologous stem-cell support for the treatment of neuroblastomaGregory A Yanik, John E Levine, Katherine K Matthay, et al.
American Journal of Respiratory and Critical Care Medicine|October 26, 2016
Parametric Response Mapping as an Imaging Biomarker in Lung Transplant RecipientsElizabeth A Belloli, Irina Degtiar, Xin Wang, et al.
Blood|July 31, 2008
The impact of soluble tumor necrosis factor receptor etanercept on the treatment of idiopathic pneumonia syndrome after allogeneic hematopoietic stem cell transplantationGregory A Yanik, Vincent T Ho, John E Levine, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 20, 2006
Phase I dose escalation of iodine-131-metaiodobenzylguanidine with myeloablative chemotherapy and autologous stem-cell transplantation in refractory neuroblastoma: a new approaches to Neuroblastoma Therapy Consortium StudyKatherine K Matthay, Jessica C Tan, Judith G Villablanca, et al.
Blood Advances|June 24, 2025
Pirfenidone for the treatment of bronchiolitis obliterans syndrome related to chronic graft-versus-host diseaseHusham Sharifi, Carson Tyler Moss, Zayan Musa, et al.
Pageof 13

Showing results (61-70 of 128) with videos related to

Sort By:
Pageof 13
Cancer Research|December 4, 2001
Vaccination of pediatric solid tumor patients with tumor lysate-pulsed dendritic cells can expand specific T cells and mediate tumor regressionJ D Geiger, R J Hutchinson, L F Hohenkirk, et al.
Bone Marrow Transplantation|January 11, 2005
Stem cell transplantation in patients with severe congenital neutropenia with evidence of leukemic transformationS W Choi, L A Boxer, M A Pulsipher, et al.
European Journal of Cancer (Oxford, England : 1990)|August 31, 2016
Incidence and risk factors for secondary malignancy in patients with neuroblastoma after treatment with (131)I-metaiodobenzylguanidineKelly E Huibregtse, Kieuhoa T Vo, Steven G DuBois, et al.
Pediatric Blood & Cancer|January 3, 2026
Parent-to-Child Information Disclosure in Pediatric OncologyRachel A Kentor, Flora Hoodin, Michelle Byrd, et al.
American Journal of Respiratory and Critical Care Medicine|September 30, 2015
Inhibition of Neutrophil Extracellular Trap Formation after Stem Cell Transplant by Prostaglandin E2Racquel Domingo-Gonzalez, Giovanny J Martínez-Colón, Alana J Smith, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2002
Pilot study of iodine-131-metaiodobenzylguanidine in combination with myeloablative chemotherapy and autologous stem-cell support for the treatment of neuroblastomaGregory A Yanik, John E Levine, Katherine K Matthay, et al.
American Journal of Respiratory and Critical Care Medicine|October 26, 2016
Parametric Response Mapping as an Imaging Biomarker in Lung Transplant RecipientsElizabeth A Belloli, Irina Degtiar, Xin Wang, et al.
Blood|July 31, 2008
The impact of soluble tumor necrosis factor receptor etanercept on the treatment of idiopathic pneumonia syndrome after allogeneic hematopoietic stem cell transplantationGregory A Yanik, Vincent T Ho, John E Levine, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 20, 2006
Phase I dose escalation of iodine-131-metaiodobenzylguanidine with myeloablative chemotherapy and autologous stem-cell transplantation in refractory neuroblastoma: a new approaches to Neuroblastoma Therapy Consortium StudyKatherine K Matthay, Jessica C Tan, Judith G Villablanca, et al.
Blood Advances|June 24, 2025
Pirfenidone for the treatment of bronchiolitis obliterans syndrome related to chronic graft-versus-host diseaseHusham Sharifi, Carson Tyler Moss, Zayan Musa, et al.
Pageof 13